12 Health Care Stocks Moving In Thursday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Thursday's pre-market session, several healthcare stocks experienced significant movements. Cingulate (CING) saw the largest increase, with shares up 188.5% to $11.51. SenesTech (SNES) and Palisade Bio (PALI) also saw substantial gains of 82.02% and 55.83%, respectively. On the losing side, Bluejay Diagnostics (BJDX) experienced the largest drop, falling 34.5% to $1.15. Other notable decliners include CytoSorbents (CTSO) and First Wave BioPharma (FWBI), with decreases of 32.52% and 15.74%, respectively.
December 28, 2023 | 1:07 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Bluejay Diagnostics' stock plummeted by 34.5% to $1.15, with a market cap of $1.4 million.
The sharp decline in Bluejay Diagnostics' stock price could reflect negative investor sentiment, potentially leading to further sell-offs in the short term.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
CytoSorbents shares decreased by 32.52% to $1.1, with their outstanding shares valued at $57.3 million.
CytoSorbents' significant pre-market drop could signal a bearish outlook, potentially leading to increased selling pressure and a negative impact on the stock price in the short term.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 100
NEGATIVE IMPACT
First Wave BioPharma's stock fell by 15.74% to $4.66, with a market value of $3.1 million for their outstanding shares.
The drop in First Wave BioPharma's stock price could indicate a negative trend that may continue into the regular trading session, potentially leading to further decreases in the short term.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Cingulate's stock soared by 188.5% to $11.51 in pre-market trading with a market cap of $10.7 million.
The substantial pre-market gain for Cingulate suggests a strong positive sentiment that could lead to increased investor interest and potentially higher trading volumes in the short term.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Palisade Bio's shares rose by 55.83% to $0.94, with a market value of $8.6 million for their outstanding shares.
Palisade Bio's notable pre-market gain could lead to heightened trading activity and potentially maintain the upward price momentum in the short term.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
SenesTech shares increased by 82.02% to $1.57, with the company's market cap at $1.1 million.
The significant rise in SenesTech's stock price indicates a positive market reaction that could attract more attention from traders and investors in the short term.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 100